Osteoporosis Testing Market

SKU: DMMD5018 | Last Updated On: Sep 08 2022 | Available Formats

>Osteoporosis Testing Market Expected to reach a high CAGR 4.9% By 2029:

Osteoporosis Testing Market is Segmented By Type (Dexa-Scan, FRAX tool, CT scans, X-rays, Other), By End User (Hospital, Diagnostic Centers, Orthopedic Clinics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.

Osteoporosis testing market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.9% during the forecast period (2022-2029). Osteoporosis testing is a type of outpatient procedure that allows physicians and rheumatologists to examine bone density. Osteoporosis is characterised by bone tissue thinning and deterioration, and a loss of calcification and density.

Osteoporosis Testing Market Dynamics

The factors influencing the global osteoporosis testing market are technological advancements and the increasing prevalence of osteoporosis.

The technological advancements are expected to drive the global osteoporosis testing market in the forecast period

Osteoporosis is a disease that causes bone tissue to deteriorate and bone strength to deteriorate. Osteoporosis is a disease that can worsen over time. This can cause the bone to become more porous (as the disease's name suggests) and more prone to breaking. Dual Energy X-ray Absorptiometry, also known as a DXA or DEXA scan, is the current gold-standard method for diagnosing osteoporosis. It usually entails visiting a large central hospital and measuring the patient's bone density. New scanning devices can now be used to detect osteoporosis in a primary care setting or during a home visit by a doctor or nurse. Patients don't need to wait for a DXA scan to get a preliminary diagnosis. A variety of technologies have been used to assess skeletal health, the most common of which is dual-energy X-ray absorptiometry (DXA), which measures the spine, hip, or entire body. The skeletal health assessment has become faster and more accurate thanks to recent advances in imaging technology. For instance, the Hologic Inc., Bedford, MA-based Discovery QDR Series bone densitometer includes High-Definition Instant Vertebral Assessment (IVA), which takes a 10-second scan of the lumbar, thoracic spine to detect vertebral deformities. This allows classifying more patients as osteoporotic, even if their BMD results are borderline. The physician can use this to take quick images and determine whether there is a vertebral compression fracture. These advancements aim to improve the DXA basic bone density system's utility in assessing overall patient health and are expected to drive market growth in the forecast period.

Limitations associated with osteoporosis testing are expected to hamper the market growth

A DXA test cannot predict who will fracture. DXA is of limited use in people with a spinal deformity or those who have had previous spinal surgery, despite its effectiveness in measuring bone density. One of the major drawbacks of DXA is that there is currently no standardisation in bone and soft tissue measurements. There are significant differences in measurements obtained on instruments from the three major DXA machine manufacturers. Moreover, high cost is also expected to hamper the market growth. For instance, the cost of the DXA instrument, which is likely to exceed $100,000, accounts for the majority of the costs associated with its use. Although DXA is better suited to lab-based research rather than field testing.

Osteoporosis Testing Market COVID-19 Impact Analysis

During the COVID-19 pandemic, screening, diagnosis, and treatment of patients with osteoporosis proved difficult. Patients' access to metabolic bone clinics has been disrupted, causing future problems due to treatment delays, particularly in denosumab patients. During the pandemic, the quality of osteoporosis care for patients who have suffered a new fragility fracture or hip fracture following surgery has deteriorated dramatically. Hence, the global osteoporosis testing market is expected to be impacted by covid-19.

Osteoporosis Testing Market Segment Analysis

The Dexa-Scan segment is expected to dominate the market growth in the forecast period

The increasing benefits of Dexa-scan are expected to drive market growth. For instance, DEXA scans, or bone density scans, determine the risk of breaking a bone. They're frequently used to diagnose or assess the risk of developing bone-related health problems like osteoporosis. DEXA scans, unlike regular X-rays, can detect even minor changes in bone density. This allows doctors to detect osteoporosis early before a bone is broken. A DEXA scan also uses a low radiation dose, resulting in far fewer health risks than traditional X-rays. A DEXA scan is a non-invasive test that measures bone mineral density and determines whether a person is at risk of osteoporosis or fracture. DEXA stands for dual-energy x-ray absorptiometry, a long name for a procedure involving two X-ray beams aimed at the bones. While a traditional X-ray can detect changes in bone density (osteopenia) after about 40% bone loss, a DEXA scan can detect changes as small as 1%, making it more sensitive and accurate. DEXA scans are central DEXA scans, bone densitometry scans, or DXA scans. The US Preventative Services Task Force and the National Osteoporosis Foundation (NOF) recommends that all women over 65 and all men over 70 have a DEXA scan at least once as a screening test for bone loss, which occurs as people age.  The age difference is because the bone loss in women is linked to the loss of estrogen that occurs with menopause, so women develop low bone mineral density earlier than men.

Osteoporosis Testing Market

Metrics

Details

Market CAGR

5%

Segments Covered

By Pet Type, By Ingredient, By Form, By Application, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Osteoporosis Testing Market Geographical Analysis

North America region is expected to hold the largest market share in the global osteoporosis testing market

The increasing prevalence of osteoporosis, the presence of key players, and better healthcare facilities are expected to drive this region's market growth. Osteoporosis is a disease that causes significant bone loss and weakening, increasing the risk of fractures. It affects people of all races and ethnicities and men and women. Osteoporosis affects an estimated 10 million people in the United States aged 50 and up. The majority of these people are women, but about 2 million men are among them. Low bone mass affects nearly 43 million more people, including 16 million men, putting them at risk for osteoporosis. Osteoporosis is expected to affect approximately 12.3 million people in the United States over 50 by 2020. The United States Preventive Services Task Force (USPSTF) recommends osteoporosis screening for women 65 and older and younger women whose fracture risk is equal to or greater than a 65-year-old white woman with no other risk factors.

Osteoporosis Testing Market Competitive Landscape

With mergers, acquisitions, and product launches, the global osteoporosis testing market is moderately competitive. Some of the key players in the market are GE Healthcare, DMS Imaging, Swissray, Hologic Inc., BeamMed Ltd, Medilink, OsteoSys

Hologic Inc.

Overview: Hologic, Inc. is a medical technology company that manufactures medical devices for diagnostics, surgery, and medical imaging, with a focus on women's health. The company was founded in 1985 and is based in Massachusetts, United States.

Product Portfolio: The Horizon DXA system is the advanced densitometry system available, but it does more than just measure bone density. The Horizon DXA system includes features such as a complete fracture risk assessment and others.

Why Purchase the Report?

  • visualize the composition of the global osteoporosis testing market segmentation by type and end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in global osteoporosis testing market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global osteoporosis testing market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global osteoporosis testing market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages. 

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest